Background and Need for Legislation
Per the Drug Enforcement Agency, drug overdoses have
officially become the leading cause of death of Americans aged
18-45, with fentanyl responsible for nearly 70% of the total
overdoses.\1\ Illicit fentanyl is typically supplied and
trafficked to the U.S. by Mexican-based transnational criminal
organizations,\2\ with China serving as the primary source for
the financing and trafficking services of fentanyl and
fentanyl-related substances (such as precursors).\3\ Mexican
drug cartels such as the Cartel Jalisco Nueva Generacion (CJNG)
and the Sinaloa Cartel are primarily responsible for the supply
of fentanyl into the U.S. through the porous southwestern
border. Chinese labs serve as the illicit manufacturer of
``fentanyl analogs and precursor chemicals used to make
fentanyl . . . [that are] then sold on the Darknet and shipped
in bulk to the U.S. and Mexico.''\4\ Generally, the two ways
fentanyl is trafficked into the U.S. by China are:
---------------------------------------------------------------------------
\1\DEA Operation Engage, https://www.dea.gov/engage/operation-
engage-spokane (last visited Feb. 13, 2025).
\2\Press Release, Dep't of the Treasury, Treasury Targets Fentanyl
Traffickers and Other Key Contributors to U.S. Opioid Crisis (Nov. 19,
2024), https://home.treasury.gov/news/press-releases/jy2719.
\3\Drug Enforcement Agency, DEA-DCT-DIR-008-20, Fentanyl Flow To
The United States (2020).
\4\Follow the Money: The CCP's Business Model Fueling the Fentanyl
Crisis: Hearing Before H. Comm. on Financial Serv., 118th Cong. 6
(2023) (written testimony of Celina B. Realuyo, Adjunct Professor, The
George Washington University Elliot School of International Affairs)
[hereinafter 2023 Realuyo Fentanyl Testimony].
---------------------------------------------------------------------------
1. U.S. individuals directly purchase fentanyl from
China for personal use or domestic distribution (via
Darknet), or
2. Fentanyl and/or other fentanyl-laced drugs are
cross-border trafficked into the U.S. by Mexican-based
transnational criminal organizations or other smaller
networks that have received the drug from China.\5\
---------------------------------------------------------------------------
\5\Id. at 8.
---------------------------------------------------------------------------
This bill ensures that Chinese entities and government
officials are held accountable by the U.S. if they take part in
the manufacturing, financing, or distribution of fentanyl.
Expanding the definition ``foreign opioid trafficker'' to
include these Chinese entities and officials allows for a more
targeted approach at dismantling Chinese money laundering
networks, given their prominent role in facilitating the
fentanyl crisis in American communities.
Committee Consideration
119TH CONGRESS
On January 28, 2025, Representative Andy Barr (R-KY)
introduced H.R. 747, the Stop Chinese Fentanyl Act of 2025,
with Representatives Zach Nunn (R-IA) and Gregory Murphy (R-NC)
as original cosponsors. Representative Mike Lawler (R-NY) was
added subsequently as a cosponsor. The bill was referred to the
Committee on Foreign Affairs and in addition to the Committees
on Financial Services, Oversight and Government Reform, and the
Judiciary.
Related Hearings
Pursuant to clause 3(c)(6) of rule XIII of the Rules of the
House of Representatives, the following hearing was used to
develop H.R. 747:
The Full Committee held a hearing on February 25, 2025,
titled ``Examining Policies to Counter China. The following
witnesses testified: John Miller, Senior Vice President of
Policy, Trust, Data, and Technology, and General Counsel,
Information Technology Industry Council; Nicholas McMurray,
Managing Director of International and Nuclear Policy,
ClearPath; John Cassara, retired United States Treasury
Department Special Agent; Martin Muhleisen, Nonresident Senior
Fellow at the GAO Economic Center at the Atlantic Council; and
Dr. Rush Doshi, C.V. Starr Senior Fellow for Asian Studies, and
Director of the China Strategy Initiative at the Council on
Foreign Relations, and an assistant professor at Georgetown
University. Among the discussion regarding the Chinese
government role in purveying fentanyl, Mr. Cassara testified
that the ``Chinese are becoming the money launderers of
choice'' for fentanyl trafficking.
The Committee on Financial Services met in open session on
March 5, 2025 to consider, among others, H.R. 747.
Committee Votes
Clause 3(b) of rule XIII of the Rules of the House of
Representatives requires the Committee Report to include for
each record vote on a motion to report the measure or matter
and on any amendments offered to the measure or matter the
total number of votes for and against and the names of the
Members voting for and against.
On March 5, 2025, the Committee ordered H.R. 747, as
amended, to be reported favorably to the House by a recorded
vote of 49 yeas and 0 nays, a quorum being present. (Record
Vote No. FC-018).
Before the question to report was called, the Committee
adopted an amendment in the nature of a substitute offered by
Mr. Barr making technical changes by voice vote.
[GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT]
Committee Oversight Findings
Pursuant to clause 3(c) of rule XIII of the Rules of the
House of Representatives, the findings and recommendations of
the Committee, based on oversight activities under clause
2(b)(1) of rule X of the Rules of the House of Representatives,
are incorporated in the descriptive portions of this report.
Performance Goals and Objectives
Pursuant to clause 3(c)(4) of rule XIII of the Rules of the
House of Representatives, the goal H.R. 747 is to include
certain Chinese entities and government officials who fail to
take steps to prevent opioid trafficking in the definition of
foreign opioid trafficker, subjecting them to sanctions.
Committee Cost Estimate
Clause 3(d)(1) of rule XIII of the Rules of the House of
Representatives requires an estimate and a comparison of the
costs that would be incurred in carrying out H.R. 747.
The Committee has requested but not received a cost
estimate from the Director of the Congressional Budget Office.
However, pursuant to clause 3(d)(1) of rule XIII of the House
of Representatives, the Committee will adopt as its own the
cost estimate by the Director of the Congressional Budget
Office once it has been prepared.
New Budget Authority and CBO Cost Estimate
With respect to the requirements of clause 3(c)(2) of rule
XIII of the Rules of the House of Representatives and section
308(a) of the Congressional Budget Act of 1974 and with respect
to requirements of clause 3(c)(3) of rule XIII of the Rules of
the House of Representatives and section 402 of the
Congressional Budget Act of 1974, a cost estimate was not made
available to the Committee in time for the filing of this
report. The Chairman of the Committee shall cause such estimate
to be printed in the Congressional Record upon its receipt by
the Committee.
Unfunded Mandates Statement
The Committee has requested but not received from the
Director of the Congressional Budget Office an estimate of the
Federal mandates pursuant to section 423 of the Unfunded
Mandates Reform Act. The Committee will adopt the estimate once
it has been prepared by the Director.
Earmark Statement
With respect to clause 9 of rule XXI of the Rules of the
House of Representatives, the Committee has carefully reviewed
the provisions of the resolution and states that the provisions
of the bill do not contain any congressional earmarks, limited
tax benefits, or limited tariff benefits within the meaning of
the rule.
Federal Advisory Committee Act Statement
No advisory committees within the meaning of section 5(b)
of the Federal Advisory Committee Act were created by this
legislation.
Applicability to the Legislative Branch
The Committee finds that the legislation does not relate to
the terms and conditions of employment or access to public
services or accommodations within the meaning of section
102(b)(3) of the Congressional Accountability Act.
Duplication of Federal Programs
Pursuant to clause 3(c)(5) of rule XIII of the Rules of the
House of Representatives, the Committee states that no
provision of the bill establishes or reauthorizes a program of
the Federal Government known to be duplicative of another
Federal program, including any program that was included in a
report to Congress pursuant to section 21 of the Public Law
111-139 or the most recent Catalog of Federal Domestic
Assistance.
Section-by-Section Analysis of the Legislation
The following is a section-by-section analysis of H.R. 747,
the Stop Chinese Fentanyl Act of 2025:
Section 1. Short title
Section 1 provides that the short title is the Stop Chinese
Fentanyl Act of 2025.
Section 2. Sense of Congress
Section 2 provides it is the Sense of Congress that the
Government of the People's Republic of China should (1) work
with the United States Government to identify a list of
unregulated chemicals used to create precursor chemicals that
bear increased scrutiny; (2) require the proper labeling of
chemical and equipment shipments in accordance with
international rules; (3) immediately implement know-your-
customer procedures for chemical shipments; and (4) direct all
relevant departments and agencies, including the National
Narcotics Control Commission, the Ministry of Public Security,
the General Administration of Customs, and the National Medical
Products Administration of the Government of the People's
Republic of China to establish new rules to crack down on
precursor trafficking and enforce such rules swiftly.
Section 3. Amendments to the Fentanyl Sanctions Act
This section amends the Fentanyl Sanctions Act to include
certain Chinese entities and government officials who fail to
take steps to prevent opioid trafficking in the definition of
foreign opioid trafficker.
Section 4. Amendments to the International Emergency Economic Powers
Act and the Trading with the Enemy Act
This section requires the President to report to
congressional committees of jurisdiction, with respect to a
covered national emergency, an assessment of the effectiveness
in resolving the fentanyl national emergency.
Section 5. Exception relating to importation of goods
This section exempts from the prohibition of transactions
sanctions on the importation of goods.
Changes in Existing Law Made by the Bill, as Reported
In compliance with clause 3(e) of rule XIII of the Rules of
the House of Representatives, changes in existing law made by
the bill, as reported, are shown as follows (existing law
proposed to be omitted is enclosed in black brackets, new
matter is printed in italics, and existing law in which no
change is proposed is shown in roman):
FENTANYL SANCTIONS ACT
TITLE LXXII--SANCTIONS WITH RESPECT TO FOREIGN TRAFFICKERS OF ILLICIT
SYNTHETIC OPIOIDS
* * * * * * *
SEC. 7203. DEFINITIONS.
In this title:
(1) Alien; national; national of the united states.--
The terms ``alien'', ``national'', and ``national of
the United States'' have the meanings given those terms
in section 101 of the Immigration and Nationality Act
(8 U.S.C. 1101).
(2) Appropriate congressional committees and
leadership.--The term ``appropriate congressional
committees and leadership'' means--
(A) the Committee on Appropriations, the
Committee on Armed Services, the Committee on
Banking, Housing, and Urban Affairs, the
Committee on Foreign Relations, the Committee
on Homeland Security and Governmental Affairs,
the Committee on the Judiciary, the Select
Committee on Intelligence, and the majority
leader and the minority leader of the Senate;
and
(B) the Committee on Appropriations, the
Committee on Armed Services, the Committee on
Financial Services, the Committee on Foreign
Affairs, the Committee on Homeland Security,
the Committee on the Judiciary, the Committee
on Oversight and Reform, the Permanent Select
Committee on Intelligence, and the Speaker and
the minority leader of the House of
Representatives.
(3) Controlled substance; listed chemical.--The terms
``controlled substance'', ``listed chemical'',
``narcotic drug'', and ``opioid'' have the meanings
given those terms in section 102 of the Controlled
Substances Act (21 U.S.C. 802).
(4) Entity.--The term ``entity'' means a partnership,
joint venture, association, corporation, organization,
network, group, or subgroup, or any form of business
collaboration.
(5) Foreign opioid trafficker.--[The term ``foreign
opioid trafficker'' means any foreign person] The term
``foreign opioid trafficker''--
(A) means any foreign person that the
President determines plays a significant role
in opioid trafficking[.]; and
(B) includes--
(i) any entity of the People's
Republic of China that the President
determines--
(I) produces, manufactures,
distributes, sells, or
knowingly finances or
transports any goods described
in clause (i) or (ii) of
paragraph (8)(A); and
(II) fails to take credible
steps, including through
implementation of appropriate
know-your-customer procedures
or through cooperation with
United States counternarcotics
efforts, to detect or prevent
opioid trafficking; and
(ii) any senior official of the
Government of the People's Republic of
China or other Chinese political
official that--
(I) has significant
regulatory or law enforcement
responsibilities with respect
to the activities of an entity
described in clause (i); and
(II) aids and abets,
including through intentional
inaction, opioid trafficking.
(6) Foreign person.--The term ``foreign person''--
(A) means--
(i) any citizen or national of a
foreign country; or
(ii) any entity not organized under
the laws of the United States or a
jurisdiction within the United States;
and
(B) does not include the government of a
foreign country.
(7) Knowingly.--The term ``knowingly'', with respect
to conduct, a circumstance, or a result, means that a
person has actual knowledge, or should have known, of
the conduct, the circumstance, or the result.
(8) Opioid trafficking.--The term ``opioid
trafficking'' means any illicit activity--
(A) to produce, manufacture, distribute,
sell, or knowingly finance or transport--
(i) synthetic opioids, including
controlled substances that are
synthetic opioids and listed chemicals
that are synthetic opioids; or
(ii) active pharmaceutical
ingredients or chemicals that are used
in the production of controlled
substances that are synthetic opioids;
(B) to attempt to carry out an activity
described in subparagraph (A); or
(C) to assist, abet, conspire, or collude
with other persons to carry out such an
activity.
(9) Person.--The term ``person'' means an individual
or entity.
(10) United states person.--The term ``United States
person'' means--
(A) any citizen or national of the United
States;
(B) any alien lawfully admitted for permanent
residence in the United States;
(C) any entity organized under the laws of
the United States or any jurisdiction within
the United States (including a foreign branch
of such an entity); or
(D) any person located in the United States.
Subtitle A--Sanctions With Respect to Foreign Opioid Traffickers
SEC. 7211. IDENTIFICATION OF FOREIGN OPIOID TRAFFICKERS.
(a) Public Report.--
(1) In general.--The President shall submit to the
appropriate congressional committees and leadership, in
accordance with subsection (c), a report--
(A) identifying the foreign persons that the
President determines are foreign opioid
traffickers, including whether the heads of the
National Narcotics Control Commission, the
Ministry of Public Security, the General
Administration of Customs, and the National
Medical Products Administration of the
Government of the People's Republic of China
are foreign opioid traffickers;
(B) detailing progress the President has made
in implementing this subtitle; and
(C) providing an update on cooperative
efforts with the governments of Mexico, the
People's Republic of China, and other countries
of concern with respect to combating foreign
opioid traffickers.
(2) Identification of additional persons.--If, at any
time after submitting a report required by paragraph
(1) and before the submission of the next such report,
the President determines that a foreign person not
identified in the report is a foreign opioid
trafficker, the President shall submit to the
appropriate congressional committees and leadership an
additional report containing the information required
by paragraph (1) with respect to the foreign person.
(3) Exclusion.--The President shall not be required
to include in a report under paragraph (1) or (2) any
persons with respect to which the United States has
imposed sanctions before the date of the report under
this subtitle or any other provision of law with
respect to opioid trafficking.
(4) Form of report.--
(A) In general.--Each report required by
paragraph (1) or (2) shall be submitted in
unclassified form but may include a classified
annex.
(B) Availability to public.--The unclassified
portion of a report required by paragraph (1)
or (2) shall be made available to the public.
(b) Classified Report.--
(1) In general.--The President shall submit to the
appropriate congressional committees and leadership, in
accordance with subsection (c), a report, in classified
form--
(A) describing in detail the status of
sanctions imposed under this subtitle,
including the personnel and resources directed
toward the imposition of such sanctions during
the preceding fiscal year;
(B) providing background information with
respect to persons newly identified as foreign
opioid traffickers and their illicit
activities;
(C) describing actions the President intends
to undertake or has undertaken to implement
this subtitle; and
(D) providing a strategy for identifying
additional foreign opioid traffickers.
(2) Effect on other reporting requirements.--The
report required by paragraph (1) is in addition to, and
in no way delimits or restricts, the obligations of the
President to keep Congress fully and currently informed
pursuant to the provisions of the National Security Act
of 1947 (50 U.S.C. 3001 et seq.).
(c) Submission of Reports.--Not later than 180 days after the
date of the enactment of this Act, and annually thereafter
until the date that is [5 years] 10 years after such date of
enactment, the President shall submit the reports required by
subsections (a) and (b) to the appropriate congressional
committees and leadership.
(d) Exclusion of Certain Information.--
(1) Intelligence.--Notwithstanding any other
provision of this section, a report required by
subsection (a) or (b) shall not disclose the identity
of any person if the Director of National Intelligence
determines that such disclosure could compromise an
intelligence operation, activity, source, or method of
the United States.
(2) Law enforcement.--Notwithstanding any other
provision of this section, a report required by
subsection (a) or (b) shall not disclose the identity
of any person if the Attorney General, in coordination,
as appropriate, with the Director of the Federal Bureau
of Investigation, the Administrator of the Drug
Enforcement Administration, the Secretary of the
Treasury, the Secretary of State, and the head of any
other appropriate Federal law enforcement agency,
determines that such disclosure could reasonably be
expected--
(A) to compromise the identity of a
confidential source, including a State, local,
or foreign agency or authority or any private
institution that furnished information on a
confidential basis;
(B) to jeopardize the integrity or success of
an ongoing criminal investigation or
prosecution;
(C) to endanger the life or physical safety
of any person; or
(D) to cause substantial harm to physical
property.
(3) Notification required.--If the Director of
National Intelligence makes a determination under
paragraph (1) or the Attorney General makes a
determination under paragraph (2), the Director or the
Attorney General, as the case may be, shall notify the
appropriate congressional committees and leadership of
the determination and the reasons for the
determination.
(4) Rule of construction.--Nothing in this section
may be construed t